Skip to main content

Table 7 Socio-demographic, clinical and life style associated potential risk factors

From: Sequel and therapeutic modalities of leptospirosis associated severe pulmonary haemorrhagic syndrome (SPHS); a Sri Lankan experience

Parameter

SPHS

No LPH

P value*

n

%

N

%

Age

< 40 years

28

59.6

19

40.4

0.7053

> 40 years

52

64.2

29

35.8

Sex

Male

68

63.6

39

36.4

0.6263

Female

12

57.1

9

42.9

Smoking

Yes

37

100.0

0

0.0

0.0091

No

43

82.7

9

17.3

Alcohol consumption

Yes

41

93.2

3

6.8

0.4845

No

39

86.7

6

13.3

Oliguria on admission

Yes

71

71.0

29

29.0

0.0003

No

9

32.1

19

67.9

Conjunctival injections

Yes

54

76.1

17

23.9

0.0005

No

26

45.6

31

54.4

Tachycardia (> 100 bpm)

Yes

70

69.3

31

30.7

0.0033

No

10

37.0

17

63.0

Hypotension

Yes

62

81.6

14

18.4

< 0.0001

No

18

34.6

34

65.4

Tachypnoea

Yes

72

80.9

17

19.1

< 0.0001

No

8

20.5

31

79.5

Arterial hypoxaemia

Yes

68

94.4

4

5.6

< 0.0001

No

12

21.4

44

78.6

Leukocytosis

Yes

69

75.0

23

25.0

< 0.0001

No

11

30.6

25

69.4

Thrombocytopenia

Yes

54

84.4

10

15.6

< 0.0001

No

26

40.6

38

59.4

  1. *Chi-square test or Fishers exact test